Skip to content
Gilenya Label Change - Monitor for Heart Problems
Elizabeth_WebMD_Staff posted:
The drug-maker, Novartis, said it has agreed with USDA to change labels on Gilenya to include recommendations for patients to be closely monitored for heart problems.

New Warnings for MS Drug Gilenya After FDA Review

In addition to cosely monitoring for macular edema, those taking the drug for the first time will require an EKG followed by hourly blood pressure and heart rate checks for the first six hours, then a follow-up EKG.

Share your experience with Gilenya. Will this label change prompt you to contact your doctor?

Do you know how to report adverse reactions? Contact MedWatch website or call 1-800-FDA-1088.


Featuring Experts

Neil S. Lava, MD, is the director of the multiple sclerosis clinic at Emory University in Atlanta. He has been treating multiple sclerosis patients si...More

Helpful Tips

Wealth of vitamin D and MS information
There is a lot of information on vitamin D and MS at VitaminDWiki. Shortcut to the MS material is . You ... More
Was this Helpful?
25 of 32 found this helpful

Related Drug Reviews

  • Drug Name User Reviews

Report Problems With Your Medications to the FDA

FDAYou are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.